top of page

welcome to our july newsletter

  • Writer: Matteo Emmanuello
    Matteo Emmanuello
  • Aug 4
  • 3 min read

As we gear up for a busy second half of the year, we’re excited to share updates from Hilo, Knowunity, Taxfix, Memo Therapeutics, and more, plus our latest articles, upcoming events, and open roles on our growing team. Read on for all of our news and highlights this month...


portfolio news

The latest updates from our portfolio:


  • Buena (RAC III) secured a $58M funding round led by Google Ventures, with 20VC, Stride.VC, and Capnamic contributing. The team is redefining real estate management using their proprietary AI-driven software and by acquiring and modernizing traditional property management operators. We invested in Buena's seed round in 2017 and are impressed with what the team has achieved under the leadership of Din Bisevac. Read more in Tech.eu


  • Hilo by Aktiia (RAC III, Summit Fund) is our second portfolio company to achieve FDA approval this month! In fact, Hilo is the first-ever cuffless blood pressure monitor approved by the FDA for over-the-counter use in the US. Starting in 2026, US consumers can access medical-grade, continuous blood pressure monitoring on the go, without any prescription needed. Read more in Fierce Biotech.


  • Hypervision Surgical (RAC VI) received FDA 510(k) clearance for its HYPERSNAP system, the first approved surgical platform to combine Hyperspectral Imaging with AI-powered analytics. This marks a major step towards improving patient safety and outcomes in the operating room. Read more here.


    They also announced a partnership with imec, a world leader in on-chip spectral sensing technology, to bring advanced spectral tissue insights closer to routine clinical use. Read more here.


  • Knowunity (RAC VI) was featured in Deutsche Welle, where co-founder Benedict Kurz shared how they became one of the world's fastest-growing EdTech startups with over 20 million users in 15 countries. Read more in Deutsche Welle.


  • Lyceum (RAC VII) was featured in the FAZ as one of Europe’s boldest players in the AI Gigafactory race. While others plan, Lyceum builds: its sovereign GPU cloud is already under construction in Denmark, powered by renewable energy and scaling toward 200MW. Read the full story in the FAZ.


  • Memo Therapeutics (RAC IV) is one step closer to tackling BK virus in kidney transplant patients. Their lead antibody potravitug showed promising Phase II results and was featured in PLOS Pathogens, highlighting a major milestone for transplant care worldwide. Read more here.


  • Taxfix (RAC III, Summit Fund) is on a mission to make financial participation more accessible. In a recent interview, CEO Martin Ott reflects on his journey from Meta to Taxfix, and why tackling financial fear through user-friendly tax tools is more urgent than ever. Read more in BusinessPunk.


what we’re writing

From why we invested in Lyceum to our thoughts on AI software pricing models - here's what we've been writing lately:


Price to win: AI redefines software economics. Four pricing insights from our team on how AI is changing value creation, business models, and competitive dynamics in SaaS. Read more

Lyceum: Reimagining access to compute in the AI era. We explored why Europe needs a sovereign GPU cloud infrastructure now, not in 2030 - and how Lyceum is leading the charge. Read more


what we're reading


Why it matters: A growing wave of startups and tech giants are reimagining the browser as a natural interface for AI-powered productivity. One of the most promising: Dia, a new browser by The Browser Company that builds generative AI directly into the browsing experience: no extra tabs, no copy-paste required. From summarizing videos to answering questions about live content, tools like Dia may reshape how we interact with information online.


 
 
bottom of page